- Home
- BDTX vs TSVT Comparison
BDTX vs TSVT Comparison
Compare BDTX & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- TSVT
- Stock Information
- Founded
- BDTX 2014
- TSVT 2021
- Country
- BDTX United States
- TSVT United States
- Employees
- BDTX N/A
- TSVT N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- BDTX Health Care
- TSVT Health Care
- Exchange
- BDTX Nasdaq
- TSVT Nasdaq
- Market Cap
- BDTX 144.9M
- TSVT 128.5M
- IPO Year
- BDTX 2020
- TSVT N/A
- Fundamental
- Price
- BDTX $2.20
- TSVT $2.61
- Analyst Decision
- BDTX Strong Buy
- TSVT Buy
- Analyst Count
- BDTX 4
- TSVT 6
- Target Price
- BDTX $15.50
- TSVT $10.40
- AVG Volume (30 Days)
- BDTX 1.2M
- TSVT 449.7K
- Earning Date
- BDTX 03-11-2025
- TSVT 03-04-2025
- Dividend Yield
- BDTX N/A
- TSVT N/A
- EPS Growth
- BDTX N/A
- TSVT N/A
- EPS
- BDTX N/A
- TSVT N/A
- Revenue
- BDTX N/A
- TSVT $45,620,000.00
- Revenue This Year
- BDTX N/A
- TSVT N/A
- Revenue Next Year
- BDTX N/A
- TSVT $36.09
- P/E Ratio
- BDTX N/A
- TSVT N/A
- Revenue Growth
- BDTX N/A
- TSVT N/A
- 52 Week Low
- BDTX $1.91
- TSVT $2.35
- 52 Week High
- BDTX $7.66
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- BDTX 46.41
- TSVT 38.77
- Support Level
- BDTX $2.02
- TSVT $2.36
- Resistance Level
- BDTX $2.33
- TSVT $2.53
- Average True Range (ATR)
- BDTX 0.18
- TSVT 0.18
- MACD
- BDTX 0.03
- TSVT 0.00
- Stochastic Oscillator
- BDTX 38.16
- TSVT 30.29
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.